Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care: Double blind randomised placebo controlled trial

BMJ (Online)

Volumn 339, Issue , 2010, Pages 83-

  Williamson, Ian ^a   Benge, Sarah ^a   Barton, Sheila ^b   Petrou, Stavros ^c   Letley, Louise ^d   Fasey, Nicky ^d   Haggard, Mark ^e   Little, Paul ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d General Practice Research Framework   (United Kingdom)

^e Elsworth House ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MOMETASONE FUROATE; PLACEBO;

AGE DISTRIBUTION; ARTICLE; ATOPY; CHILD; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COUGHING; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRY THROAT; EPISTAXIS; FEMALE; GENERAL PRACTICE; HEARING IMPAIRMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE EAR EFFUSION; MULTICENTER STUDY; NOSE DISEASE; OTALGIA; OTITIS MEDIA; OTOSCOPY; PERSISTENT INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEASONAL VARIATION; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; TYMPANOMETRY;

ADMINISTRATION, INTRANASAL; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; OTITIS MEDIA WITH EFFUSION; PREGNADIENEDIOLS; TREATMENT OUTCOME;

EID: 74949091958     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b4984     Document Type: Article

References (34)

1. Stool SE, Berg AO, Berman S, Carney CJ, Cooley JR, Culpepper L, et al. Otitis media with effusion in children. 1994. www.ncbi.nlm.nih.gov/bookshelf/br. fcgi?book=hsarchive&part=A34095.
2. Williamson I, Benge S, Mullee M, Little P. Consultations for middle ear disease, antibiotic prescribing and risk factors for re-attendance: a case linked cohort study. Br J Gen Pract 2006;56:170-5.
3. Department of Health. Trends in children's surgery 1994-2005: evidence from hospital episode statistics data. Stationery Office, 2007 (available at www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsStatistics/ DH-066322).
4. Haggard MP, Smith SC. Impact of otitis media on child quality of life. In: Rosenfeld RM, Bluestone CD, eds. Evidence based otitis media. BC Decker, 1999:375-98.
5. Zielhuis GA, Rach GH, Broek PV. Screening for otitis media with effusion in preschool children. Lancet 1989;1:311-4.
6. Hogan SC, Stratford KJ, Moore DR. Duration and recurrence of otitis media with effusion in children from birth to 3 years: prospective study using monthly otoscopy and tympanometry. BMJ 1997;314:350-3.
7. Williamson IG, Dunleavey J, Bain J, Robinson D. The natural history of otitis media with effusion - a three year study of the incidence and prevalence of abnormal tympanograms in four south west infant and first schools. J Laryngol Otol 1994;108:930-4.
8. National Institute for Health and Clinical Excellence. Surgical management of otitis media with effusion in children. NICE, 2008 (available at www.nice.org.uk/nicemedia/pdf/CG60NICEguideline.pdf).
9. Browning GG. Watchful waiting in childhood otitis media with effusion. Clin Otolaryngol Allied Sci 2001;26:263-4.
10. Lous J, Burton M, Felding J, Ovesen T, Rovers MM, Williamson I. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev 2005;(1):CD001801.
11. Maw AR. Using tympanometry to detect glue ear in general practice. BMJ 1992;304:67-8.
12. Perera R, Haynes J, Glasziou P, Heneghan CJ. Autoinflation for hearing loss associated with otitis media with effusion. Cochrane Database Syst Rev 2006;(4):CD006285.
13. Tracy JM, Demain JG, Hoffman KM, Goetz DW. Intranasal beclomethasone as an adjunct to treatment of chronic middle ear effusion. Ann Allergy Asthma Immunol 1998;80:198-206.
14. Fokkens WJ, Scadding GK. Perennial rhinitis in the under 4s: a difficult problem to treat safely and effectively? A comparison of intranasal fluticasone proprionate and ketotifen in the treatment of 2-4 year old children with perennial rhinitis. Ped Allergy Immunol 2004;15:261-6.
15. Cengel S, Akyol MU. The role of topical nasal steroids in the treatment of children with otitismedia with effusion and/or adenoid hypertrophy. Int J Ped Otorhinolaryngol 2006;70:639-45.
16. Yaman H, Ozturk K, Uyar Y, Gurbilek M. Effectiveness of corticosteroids in otitismedia with effusion: an experimental study. J Laryngol Otol 2008;122:25-30.
17. Rosenfeld RM, Mandel EM, Bluestone CD. Systemic steroids for otitis media with effusion in children. Arch Otolaryngol Head Neck Surg 1991;117:984-9.
18. Butler CC, Van der Voort JH. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev 2006;(3):CD001935.
19. Williamson I. Otitis media with effusion. Clin Evid 2006;15:814-21.
20. Barek PJ, Bergman DA, Ducharme F. Beclomethasone for asthma in children: effects on linear growth. Cochrane Database Syst Rev 1999;(3):CD001282.
21. Shenkel EJ, Skoner DP, Bronsky EA, Miller D, Pearlman DS, Rooklin A, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000;105:e22.
22. Skoner DP, Rachelefsky GS, Meltzer EO, Chervinsky P, Morris RM, Seltzer JM, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone diproprionate. Pediatrics 2000;105:e22.
23. Fiellau-Nikolajsen M. Epidemiology of secretory otitis media; a descriptive cohort study. Ann Otol Rhinol Laryngol 1983;92:172-7.
24. Jerger J. Clinical experience with impedance audiometry. Arch Otolaryngol 1970;92:311-24.
25. Van Balen FAM, de Melker RA, Touw-Otten FW. Double blind randomized trial of co-amoxiclav versus placebo for persistent otitis media with effusion in general practice. Lancet 1996;348:713-6.
26. Haggard M, Spencer H, Williamson I, Benge SE. Caseloads in otitis media: effects of season and selective referral to secondary care [abstract 5SOP1]. 8th ESPO International Conference, Budapest, June 2008.
27. Bisset A. Treatment of glue ear in general practice. Lancet 1996;349:134.
28. Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ 2001;322:336-42.
29. Williamson I, Rumsby K, Benge S, Moore M, Smith P, Cross M, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a double blind randomized placebo controlled trial. JAMA 2007;298:2487-96.
30. Dempster JH, Mackenzie K. Tympanometry and the detection of hearing impairment associated with otitis media with effusion. Clin Otolaryngol 1991;16:157-9.
31. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-6.
32. Mendes Leal M, Marques P, Vaz R, Sprately J, Haggard M, Spencer H. Factors in severity of OME seen in secondary care [abstract 5SOP4]. 8th ESPO International Conference, Budapest, June 2008.
33. Williamson I, Benge S, Barton S, Petrou S, Letley L, Fasey N, et al. A double-blind randomised placebo controlled trial of topical intranasal corticosteroids in 4- to 11-year old children with persistent bilateral otitis media with effusion in primary care. Health Technol Assess 2009;13(37):1-144.
34. Nondahl DM, Cruickshanks KJ, Wiley TL, Tweed TS, Klein R, Klein BE. Accuracy of self-reported hearing loss. Audiology 1998;37:295-310.